BNET Industries
Last Fiscal Year Sales:$430.9M
- Private
- US
Dow Jones Description
Mfr of Generic Pharmaceutical Products
Vice President, Sales, Marketing
Frank J. FeraNumber of Employees 539
Contact Information
22715 N Conduit Ave
Laurelton, New York 11413-3134
(718) 276-8600
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
News & Analysis
Filter by
eon labs - All News and Analysis
Eon Labs Begins Shipping Itraconazole Capsules
- 2005-02-09
LAKE SUCCESS, N.Y. -- Eon Labs, Inc. (Nasdaq: ELAB) announced today that it began shipping Itraconazole 100mg capsules, the generic equivalent to SporanoxR* capsules. As the first company to file an ANDA with a Paragraph IV patent certification for this product, Eon Labs is entitled to 180 days of market...
Eon Labs Receives Favorable District Court Ruling on Itraconazole Capsules
- 2004-07-30
LAURELTON, N.Y. -- Eon Labs, Inc. (Nasdaq: ELAB) announced today that the U.S. District Court for the Eastern District of New York granted judgment in favor of Eon Labs ruling that, while the validity of the patent was upheld, the Company's Itraconazole 100mg capsules does not infringe Janssen Pharmaceutica N.V....
Getting poised for a steeper growth curve
- 2003-02-17
New YORK -- The winds of change have begun to fill the generic drug industry's sails. Driven by expiring patents on big-selling blockbuster drugs and the frantic search for lower-cost prescription alternatives by health plan payers, generic utilization rates have grown roughly 6 percent by volume over the past two...
Eon Labs, Mylan Pharmaceuticals enter agreement to co-promote generic cyclosporine softgel capsules to hospitals
- 2000-04-28
Eon Labs Manufacturing, Inc., Laurelton, NY, announced it has entered into a co-promotion with the Institutional Division of Mylan Pharmaceuticals, Inc. to detail Eon's Cyclosporine Softgel Capsules, USP modified to hospitals, in the brand equivalent strengths of 25mg and 100 mg. The co-promotion, which begins this month, combines Mylan's...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Frank J. Fera | Vice President, Sales, Marketing |
| David H. Gransee | Controller |
| Douglas M Karp | Director |
| Organization | Position | Status |
|---|---|---|
| Eon Labs, Inc | Vice President, Sales, Marketing | Current |
David H. Gransee, Age 56, has served as our Vice President and Chief Financial Officer since 2006. Prior to joining the Company, Mr. Gransee had been the Controller and Assistant Secretary of Eon Labs, Inc., a publicly traded pharmaceutical company with revenue in excess of $400 million, since its inception in 1992. Mr. Gransee received his Bachelor of Science degree in Accounting from DePaul University.
| Organization | Position | Status |
|---|---|---|
| Manitex International, Inc. | Cfo & Vice President | Current |
| Eon Labs, Inc | Controller | Current |
| Eon Labs, Inc | Board of Directors | Former |
| DePaul University | Bachelor of Science In Commerce | Former |
| Organization | Position | Status |
|---|---|---|
| Tailwind Capital Partners, LLC | Managing Partner | Current |
| Tailwind, Inc | Current | |
| Primus Telecommunications Group, Inc. | Board of Directors | Current |
| City Parks Foundation | Board of Directors | Current |
| Aircast, Incorporated | Director | Current |
| Eon Labs, Inc | Director | Current |
| Primus Telecommunications, Inc. | Director | Current |
| Concord Music Group, Inc | Director | Current |
| Trover Solutions, Inc. | Director | Current |
| Food Company, Inc. | Director | Current |
| Tailwind Capital Partners, LLC | Co-Chief Executive Officer | Former |
| Salomon Brothers | COO | Former |
| Pacific Partners | Managing Partner | Former |
| Warburg Pincus, LLC | Partner | Former |
| Salomon Brothers | Partner | Former |
| The Boston Consulting Group, Inc. | Consultant | Former |
| Harvard Law School | JD | Former |
| Yale University | BA | Former |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
